EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dl-3-n-Butylphthalide Protects Human Brain Microvascular Endothelial Cells Against Ischemic Injury Through Dual Modulation of HIF1α/VEGF-Mediated Angiogenesis and COX2-Mediated Inflammation

Yanyan Wang, Chuanxin Su, Teng Chen, Shijia Chen, Zhenzhong Li, Lihong Zhang

Journal of Integrative Neuroscience · 21.07.2026 · 25 (7)

DOI: 10.31083/jin51032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 21.07.2026. Verfasst von Yanyan Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Hospital of Hebei Medical University, 050000 Shijiazhuang, Hebei, China. Hauptthemen laut MEDLINE: Benzofurans, Cyclooxygenase 2, Endothelial Cells, Vascular Endothelial Growth Factor A. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hebei Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Stroke remains a leading cause of death and disability worldwide. Endothelial dysfunction plays a central role in both acute ischemic injury and subsequent recovery. In this study, we investigated the protective effects and underlying mechanisms of Dl-3-n-butylphthalide (NBP) on human brain microvascular endothelial cells (HBMECs) subjected to oxygen-glucose deprivation (OGD), an in vitro model of ischemic stroke.Methods:HBMECs were divided into three groups: control (normoxia), OGD (10 h hypoxia, followed by reoxygenation for different durations (0–24 h), and then a subsequent 24 h incubation), and NBP-treated OGD (10 μmol/L NBP during reoxygenation). Cell viability and apoptosis were assessed by Cell Counting Kit 8 (CCK8), lactate dehydrogenase (LDH) release, and flow cytometry. Mitochondrial function was evaluated using MitoTracker fluorescence. Molecular mechanisms were examined using Western blot, quantitative real-time PCR (qRT-PCR), immunofluorescence, and enzyme-linked immunosorbent assay (ELISA), focusing on the hypoxia-inducible factor-1α (HIF1α)/vascular endothelial growth factor (VEGF) angiogenic pathway and cyclooxygenase-2 (COX2)-mediated inflammatory response.Results:NBP at 10 μmol/L significantly improved HBMEC viability (37.5% increase, p < 0.01), reduced apoptosis (p < 0.01), and restored mitochondrial membrane potential (p < 0.05) following OGD injury. Mechanistically, NBP demonstrated dual pathway modulation by: (1) promoting angiogenesis-related gene expression through HIF1α upregulation and subsequent increase in vascular endothelial growth factor receptor 2 (VEGFR2) and endothelial nitric oxide synthase (eNOS) expression (p < 0.05); and (2) suppressing inflammation via COX2 downregulation with concurrent reduction of downstream mediators including inducible nitric oxide synthase (iNOS), tumor necrosis factor-α (TNFα), interleukin-1β (IL-1β), and Thromboxane B2 (TXB2, p < 0.05). This coordinated regulation created a favorable microenvironment balancing pro-angiogenic signals with anti-inflammatory effects.Conclusion:NBP exerts multi-targeted protection on HBMECs after ischemic injury through associated with the activation of HIF1α/VEGF-mediated angiogenesis and suppression of COX2-driven inflammation. This dual modulation strategy, targeting both vascular repair and inflammatory control, provides preliminary in vitro mechanistic insights that warrant further validation in vivo and in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzofuransCyclooxygenase 2Endothelial CellsVascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitBrain IschemiaNeuroprotective AgentsAngiogenesisBrainInflammationHumansMicrovesselsCells, Cultured

Stichwörter der Autor:innen

Dl-3-n-butylphthalideangiogenesishuman brain microvascular endothelial cellsinflammationischemic stroke

Substanzen

Benzofurans3-n-butylphthalideCyclooxygenase 2Vascular Endothelial Growth Factor AHypoxia-Inducible Factor 1, alpha SubunitNeuroprotective AgentsHIF1A protein, humanVEGFA protein, humanPTGS2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, The Second Hospital of Hebei Medical University, 050000 Shijiazhuang, Hebei, China.
  • The Key Laboratory of Neurology (Hebei Medical University), Ministry of Education, 050000 Shijiazhuang, Hebei, China.
  • Neurological Laboratory of Hebei Province, 050000 Shijiazhuang, Hebei, China.
  • Department of Rheumatology and Immunology, Peking University People's Hospital Qingdao Hospital, 266011 Qingdao, Shandong, China.
  • Institute of System Medicine, Zhejiang University School of Medicine, 310000 Hangzhou, Zhejiang, China.

Förderung

  • Hebei Provincial Natural Science Foundation of China

Zitieren

APA

Wang, Y., Su, C., Chen, T., Chen, S., Li, Z., & Zhang, L. (2026). Dl-3-n-Butylphthalide Protects Human Brain Microvascular Endothelial Cells Against Ischemic Injury Through Dual Modulation of HIF1α/VEGF-Mediated Angiogenesis and COX2-Mediated Inflammation. Journal of Integrative Neuroscience, 25(7). https://doi.org/10.31083/jin51032

Vancouver

Wang Y, Su C, Chen T, Chen S, Li Z, Zhang L. Dl-3-n-Butylphthalide Protects Human Brain Microvascular Endothelial Cells Against Ischemic Injury Through Dual Modulation of HIF1α/VEGF-Mediated Angiogenesis and COX2-Mediated Inflammation. Journal of Integrative Neuroscience. 2026;25(7). doi:10.31083/jin51032

BibTeX
@article{Wang2026,
  author = {Wang, Yanyan and Su, Chuanxin and Chen, Teng and Chen, Shijia and Li, Zhenzhong and Zhang, Lihong},
  title = {Dl-3-n-Butylphthalide Protects Human Brain Microvascular Endothelial Cells Against Ischemic Injury Through Dual Modulation of HIF1α/VEGF-Mediated Angiogenesis and COX2-Mediated Inflammation},
  journal = {Journal of Integrative Neuroscience},
  year = {2026},
  volume = {25},
  number = {7},
  doi = {10.31083/jin51032}
}
Kostenlos starten →